These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 16679757)
21. Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies. Yang CW; Hsueh S; Wu MS; Lai PC; Huang JY; Wu CH; Hu SA; Chen JF; Huang CC Nephron; 1997; 77(3):290-7. PubMed ID: 9375822 [TBL] [Abstract][Full Text] [Related]
22. Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta. Baroni EA; Costa RS; da Silva CG; Coimbra TM Nephron; 2000 Mar; 84(3):248-57. PubMed ID: 10720896 [TBL] [Abstract][Full Text] [Related]
23. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. Agarwal R; Siva S; Dunn SR; Sharma K Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567 [TBL] [Abstract][Full Text] [Related]
24. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis. Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406 [TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. Baricos WH; Cortez SL; Deboisblanc M; Xin S J Am Soc Nephrol; 1999 Apr; 10(4):790-5. PubMed ID: 10203363 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Abbate M; Zoja C; Morigi M; Rottoli D; Angioletti S; Tomasoni S; Zanchi C; Longaretti L; Donadelli R; Remuzzi G Am J Pathol; 2002 Dec; 161(6):2179-93. PubMed ID: 12466133 [TBL] [Abstract][Full Text] [Related]
27. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Cosgrove D; Rodgers K; Meehan D; Miller C; Bovard K; Gilroy A; Gardner H; Kotelianski V; Gotwals P; Amatucci A; Kalluri R Am J Pathol; 2000 Nov; 157(5):1649-59. PubMed ID: 11073824 [TBL] [Abstract][Full Text] [Related]
28. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan]. Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535 [TBL] [Abstract][Full Text] [Related]
29. Urinary transforming growth factor-beta1 levels correlate with bladder outlet obstruction. Monga M; Gabal-Shehab LL; Stein P Int J Urol; 2001 Sep; 8(9):487-9. PubMed ID: 11683968 [TBL] [Abstract][Full Text] [Related]
31. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy. Park HC; Xu ZG; Choi S; Goo YS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343 [TBL] [Abstract][Full Text] [Related]
32. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation. Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771 [TBL] [Abstract][Full Text] [Related]
33. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939 [TBL] [Abstract][Full Text] [Related]
34. Urinary excretion of endothelin-1 (ET-1), transforming growth factor- beta1 (TGF- beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial. Grenda R; Wühl E; Litwin M; Janas R; Sladowska J; Arbeiter K; Berg U; Caldas-Afonso A; Fischbach M; Mehls O; Sallay P; Schaefer F; Nephrol Dial Transplant; 2007 Dec; 22(12):3487-94. PubMed ID: 17901069 [TBL] [Abstract][Full Text] [Related]
35. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363 [TBL] [Abstract][Full Text] [Related]
36. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939 [TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Ma LJ; Yang H; Gaspert A; Carlesso G; Barty MM; Davidson JM; Sheppard D; Fogo AB Am J Pathol; 2003 Oct; 163(4):1261-73. PubMed ID: 14507636 [TBL] [Abstract][Full Text] [Related]
38. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls. Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222 [TBL] [Abstract][Full Text] [Related]